Breast Cancer

In an article in U.S. News and World Report, Reshma Jagsi, M.D., D.Phil., describes recent advances in radiation therapy to treat breast cancer.

The Wall Street Journal looks at efforts to improve how oncologists determine which patients need chemotherapy. What once was a crucial part of cancer treatment might now be best avoided for some patients at low risk. The article cites research from U-M Rogel Cancer Center member Steven Katz, M.D., MPH.

Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators published in the New England Journal of Medicine.

As cancer grows, it evolves. Individual cells become more aggressive, break away to flow through the body and spread to distant areas. What if there were a way to find those early aggressors? How are they different from the rest of the cells? And more importantly: Is there a way to stop them before they spread?

A new study finds doctors are appropriately using a genetic test to measure breast cancer recurrence risk and to make tailored treatment recommendations.

University of Michigan Rogel Cancer Center breast cancer researchers discuss the amazing progress of breast cancer research over the past decades and look ahead to the day when it's understood exactly how and why breast cancer spreads so it can be stopped.

Women who pursue a more aggressive surgery for early stage breast cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Rogel Cancer Center researchers.